The biotech bi-weekly: analyzing methylated DNA, accelerating rare disease research with global data and more

From the unveiling of a cloud-based computational platform for metabolomics data analysis, to demonstrating the efficacy and safety of therapeutic antibodies using an innovative mouse model, here are the key biotech industry announcements from the past 2 weeks. What’s coming up at ABRF 2026? The ABRF Annual Meeting is back! It will be held at the David L. Lawrence Convention Center in Pittsburgh (PA, USA) from 28–31 March. Here, we highlight the breakout sessions you won’t want to miss. Products Enabling analysis of methylated DNA Syndex Bio (Cambridge, UK), a biotechnology company advancing next‑generation molecular diagnostics, has announced the introduction...